Key Financial Data Of Reporting Company

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7316972

Concept As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
149,221,000,000 JPY
227,934,000,000 JPY
124,003,000,000 JPY
208,859,000,000 JPY
123,302,000,000 JPY
165,615,000,000 JPY
115,346,000,000 JPY
154,900,000,000 JPY
107,654,000,000 JPY
110,384,000,000 JPY
Ordinary profit (loss)
27,231,000,000 JPY
24,477,000,000 JPY
8,542,000,000 JPY
5,141,000,000 JPY
22,493,000,000 JPY
22,739,000,000 JPY
18,630,000,000 JPY
18,677,000,000 JPY
21,699,000,000 JPY
20,990,000,000 JPY
Profit (loss)
19,600,000,000 JPY
6,329,000,000 JPY
16,318,000,000 JPY
13,651,000,000 JPY
15,254,000,000 JPY
Share capital
4,717,000,000 JPY
4,717,000,000 JPY
4,717,000,000 JPY
4,717,000,000 JPY
4,717,000,000 JPY
Total number of issued shares
51,516,000 xbrli:shares
51,516,000 xbrli:shares
51,516,000 xbrli:shares
51,516,000 xbrli:shares
51,516,000 xbrli:shares
Net assets
155,893,000,000 JPY
150,530,000,000 JPY
133,798,000,000 JPY
136,894,000,000 JPY
132,169,000,000 JPY
130,575,000,000 JPY
116,599,000,000 JPY
116,658,000,000 JPY
104,665,000,000 JPY
105,126,000,000 JPY
Total assets
430,653,000,000 JPY
383,843,000,000 JPY
333,620,000,000 JPY
371,347,000,000 JPY
332,097,000,000 JPY
299,893,000,000 JPY
245,668,000,000 JPY
230,501,000,000 JPY
230,016,000,000 JPY
214,507,000,000 JPY
Net assets per share
3,167.27
3,058.31
2,718.28
2,781.17
2,685.18
2,652.79
2,369.21
2,370.40
2,126.72
2,136.10
Dividend paid per share
60.00
60.00
60.00
44.00
44.00
Interim dividend paid per share
30.00
30.00
27.00
22.00
22.00
Basic earnings (loss) per share
398.21
328.59
128.60
44.72
331.57
323.36
277.39
283.62
309.99
294.74
Diluted earnings per share
324.22
316.19
265.95
271.93
286.73
272.62
Equity-to-asset ratio
0.362 xbrli:pure
0.392 xbrli:pure
0.401 xbrli:pure
0.369 xbrli:pure
0.398 xbrli:pure
0.435 xbrli:pure
0.475 xbrli:pure
0.506 xbrli:pure
0.455 xbrli:pure
0.490 xbrli:pure
Rate of return on equity
0.138 xbrli:pure
0.110 xbrli:pure
0.048 xbrli:pure
0.016 xbrli:pure
0.132 xbrli:pure
0.128 xbrli:pure
0.123 xbrli:pure
0.126 xbrli:pure
0.155 xbrli:pure
0.148 xbrli:pure
Price-earnings ratio
7.29 xbrli:pure
8.84 xbrli:pure
14.74 xbrli:pure
42.37 xbrli:pure
8.29 xbrli:pure
8.50 xbrli:pure
8.81 xbrli:pure
8.61 xbrli:pure
7.31 xbrli:pure
7.69 xbrli:pure
Payout ratio
0.151 xbrli:pure
0.467 xbrli:pure
0.181 xbrli:pure
0.159 xbrli:pure
0.142 xbrli:pure
Net cash provided by (used in) operating activities
8,212,000,000 JPY
2,544,000,000 JPY
22,129,000,000 JPY
12,008,000,000 JPY
19,164,000,000 JPY
Net cash provided by (used in) investing activities
-40,394,000,000 JPY
-30,284,000,000 JPY
-59,729,000,000 JPY
-9,100,000,000 JPY
-39,541,000,000 JPY
Net cash provided by (used in) financing activities
35,407,000,000 JPY
17,481,000,000 JPY
46,540,000,000 JPY
184,000,000 JPY
11,748,000,000 JPY
Cash and cash equivalents
29,650,000,000 JPY
24,257,000,000 JPY
32,830,000,000 JPY
22,915,000,000 JPY
18,713,000,000 JPY
Number of employees
3,712 xbrli:pure
876 xbrli:pure
4,588 xbrli:pure
2,684 xbrli:pure
2,591 xbrli:pure
4,298 xbrli:pure
4,078 xbrli:pure
2,449 xbrli:pure
3,456 xbrli:pure
2,408 xbrli:pure
3,325 xbrli:pure
2,321 xbrli:pure
Average number of temporary employees
761 xbrli:pure
xbrli:pure
761 xbrli:pure
651 xbrli:pure
681 xbrli:pure
837 xbrli:pure
852 xbrli:pure
705 xbrli:pure
684 xbrli:pure
684 xbrli:pure
666 xbrli:pure
666 xbrli:pure
Total shareholder return
1.089 xbrli:pure
0.722 xbrli:pure
0.994 xbrli:pure
0.869 xbrli:pure
0.793 xbrli:pure
Total return on share price index
1.962 xbrli:pure
1.388 xbrli:pure
1.312 xbrli:pure
1.286 xbrli:pure
0.905 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.